17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?

William D, Bermúdez M, Kübler A, Kahlert C, Distler M, Weitz J, Uhrig S, Fröhlich M, Hutter B, Aust D, Baretton G, Wimberger P, Kast K, Meisel C, Gieldon L, Porrmann J, Wagner J, Arlt M, Franke M, Fischer J, Hackmann K, Kreutzfeldt S, Mock A, Heilig CE, Lipka DB, Teleanu MV, Schlenk RF, Brors B, Hübschmann D, Paramasivam N, Richter D, Beck K, Pfütze K, Buchhalter I, Weichert W, Herold T, Spiekermann K, Jost PJ, Keilholz U, Klauschen F, Bauer S, Siveke JT, Kindler T, Boerries M, Illert AL, Bitzer M, Schulze-Osthoff K, Schirmacher P, Stenzinger A, Horak P, Heining C, Folprecht G, Fröhling S, Glimm H, Schröck E, Jahn A

Open source

DOI
10.1016/j.esmogo.2025.100218
Published
2025 Sep
Container
ESMO gastrointestinal oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.esmogo.2025.100218,
  title = {17.6\% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?},
  author = {William D and Bermúdez M and Kübler A and Kahlert C and Distler M and Weitz J and Uhrig S and Fröhlich M and Hutter B and Aust D and Baretton G and Wimberger P and Kast K and Meisel C and Gieldon L and Porrmann J and Wagner J and Arlt M and Franke M and Fischer J and Hackmann K and Kreutzfeldt S and Mock A and Heilig CE and Lipka DB and Teleanu MV and Schlenk RF and Brors B and Hübschmann D and Paramasivam N and Richter D and Beck K and Pfütze K and Buchhalter I and Weichert W and Herold T and Spiekermann K and Jost PJ and Keilholz U and Klauschen F and Bauer S and Siveke JT and Kindler T and Boerries M and Illert AL and Bitzer M and Schulze-Osthoff K and Schirmacher P and Stenzinger A and Horak P and Heining C and Folprecht G and Fröhling S and Glimm H and Schröck E and Jahn A},
  year = {2025},
  journal = {ESMO gastrointestinal oncology},
  doi = {10.1016/j.esmogo.2025.100218},
  url = {https://doi.org/10.1016/j.esmogo.2025.100218}
}

RIS

TY  - JOUR
TI  - 17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?
AU  - William D
AU  - Bermúdez M
AU  - Kübler A
AU  - Kahlert C
AU  - Distler M
AU  - Weitz J
AU  - Uhrig S
AU  - Fröhlich M
AU  - Hutter B
AU  - Aust D
AU  - Baretton G
AU  - Wimberger P
AU  - Kast K
AU  - Meisel C
AU  - Gieldon L
AU  - Porrmann J
AU  - Wagner J
AU  - Arlt M
AU  - Franke M
AU  - Fischer J
AU  - Hackmann K
AU  - Kreutzfeldt S
AU  - Mock A
AU  - Heilig CE
AU  - Lipka DB
AU  - Teleanu MV
AU  - Schlenk RF
AU  - Brors B
AU  - Hübschmann D
AU  - Paramasivam N
AU  - Richter D
AU  - Beck K
AU  - Pfütze K
AU  - Buchhalter I
AU  - Weichert W
AU  - Herold T
AU  - Spiekermann K
AU  - Jost PJ
AU  - Keilholz U
AU  - Klauschen F
AU  - Bauer S
AU  - Siveke JT
AU  - Kindler T
AU  - Boerries M
AU  - Illert AL
AU  - Bitzer M
AU  - Schulze-Osthoff K
AU  - Schirmacher P
AU  - Stenzinger A
AU  - Horak P
AU  - Heining C
AU  - Folprecht G
AU  - Fröhling S
AU  - Glimm H
AU  - Schröck E
AU  - Jahn A
PY  - 2025
JO  - ESMO gastrointestinal oncology
DO  - 10.1016/j.esmogo.2025.100218
UR  - https://doi.org/10.1016/j.esmogo.2025.100218
ER  -

APA

D, W., M, B., A, K., C, K., M, D., J, W., S, U., M, F., B, H., D, A., G, B., P, W., K, K., C, M., L, G., J, P., J, W., M, A., M, F., J, F., K, H., S, K., A, M., CE, H., DB, L., MV, T., RF, S., B, B., D, H., N, P., D, R., K, B., K, P., I, B., W, W., T, H., K, S., PJ, J., U, K., F, K., S, B., JT, S., T, K., M, B., AL, I., M, B., K, S., P, S., A, S., P, H., C, H., G, F., S, F., H, G., E, S., & A, J. (2025). 17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?. ESMO gastrointestinal oncology. https://doi.org/10.1016/j.esmogo.2025.100218

Source records